United States (US) Biologics Market (2024-2030) | Companies, Analysis, Forecast, Industry, Trends, Revenue, Outlook, Growth, Size, Share & Value

Market Forecast By Source (Microbial, Mammalian, Others), By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense, RNAi, & Molecular Therapy, Others), By Diseaseย  Category (Oncology, Infectious Diseases, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others), By Biologics Manufacturing (Outsourced, In-house) And Competitive Landscape
Product Code: ETC052421 Publication Date: Jan 2021 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Key Highlights of the Report:

  • United States (US) Biologics Market Outlook
  • Market Size of United States (US) Biologics Market, 2023
  • Forecast of United States (US) Biologics Market, 2026
  • Historical Data and Forecast of United States (US) Biologics Revenues & Volume for the Period 2020 - 2030
  • United States (US) Biologics Market Trend Evolution
  • United States (US) Biologics Market Drivers and Challenges
  • United States (US) Biologics Price Trends
  • United States (US) Biologics Porter's Five Forces
  • United States (US) Biologics Industry Life Cycle
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Source for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Microbial for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Mammalian for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Product Type for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Monoclonal Antibodies for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Vaccines for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Recombinant Proteins for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Antisense, RNAi, & Molecular Therapy for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Disease? Category for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Oncology for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Infectious Diseases for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Immunological Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Cardiovascular Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Hematological Disorders for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Others for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Biologics Manufacturing for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By Outsourced for the Period 2020 - 2030
  • Historical Data and Forecast of United States (US) Biologics Market Revenues & Volume By In-house for the Period 2020 - 2030
  • United States (US) Biologics Import Export Trade Statistics
  • Market Opportunity Assessment By Source
  • Market Opportunity Assessment By Product Type
  • Market Opportunity Assessment By Disease? Category
  • Market Opportunity Assessment By Biologics Manufacturing
  • United States (US) Biologics Top Companies Market Share
  • United States (US) Biologics Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Biologics Company Profiles
  • United States (US) Biologics Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Biologics Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Biologics Market Revenues & Volume, 2019 & 2026F

3.3 United States (US) Biologics Market - Industry Life Cycle

3.4 United States (US) Biologics Market - Porter's Five Forces

3.5 United States (US) Biologics Market Revenues & Volume Share, By Source, 2020 & 2030F

3.6 United States (US) Biologics Market Revenues & Volume Share, By Product Type, 2019 & 2026F

3.7 United States (US) Biologics Market Revenues & Volume Share, By Diseaseย  Category, 2019 & 2026F

3.8 United States (US) Biologics Market Revenues & Volume Share, By Biologics Manufacturing, 2019 & 2026F

4 United States (US) Biologics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Biologics Market Trends

6 United States (US) Biologics Market, By Types

6.1 United States (US) Biologics Market, By Source

6.1.1 Overview and Analysis

6.1.2 United States (US) Biologics Market Revenues & Volume, By Source, 2016 - 2026F

6.1.3 United States (US) Biologics Market Revenues & Volume, By Microbial, 2016 - 2026F

6.1.4 United States (US) Biologics Market Revenues & Volume, By Mammalian, 2016 - 2026F

6.1.5 United States (US) Biologics Market Revenues & Volume, By Others, 2016 - 2026F

6.2 United States (US) Biologics Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Biologics Market Revenues & Volume, By Monoclonal Antibodies, 2016 - 2026F

6.2.3 United States (US) Biologics Market Revenues & Volume, By Vaccines, 2016 - 2026F

6.2.4 United States (US) Biologics Market Revenues & Volume, By Recombinant Proteins, 2016 - 2026F

6.2.5 United States (US) Biologics Market Revenues & Volume, By Antisense, RNAi, & Molecular Therapy, 2016 - 2026F

6.2.6 United States (US) Biologics Market Revenues & Volume, By Others, 2016 - 2026F

6.3 United States (US) Biologics Market, By Diseaseย  Category

6.3.1 Overview and Analysis

6.3.2 United States (US) Biologics Market Revenues & Volume, By Oncology, 2016 - 2026F

6.3.3 United States (US) Biologics Market Revenues & Volume, By Infectious Diseases, 2016 - 2026F

6.3.4 United States (US) Biologics Market Revenues & Volume, By Immunological Disorders, 2016 - 2026F

6.3.5 United States (US) Biologics Market Revenues & Volume, By Cardiovascular Disorders, 2016 - 2026F

6.3.6 United States (US) Biologics Market Revenues & Volume, By Hematological Disorders, 2016 - 2026F

6.3.7 United States (US) Biologics Market Revenues & Volume, By Others, 2016 - 2026F

6.4 United States (US) Biologics Market, By Biologics Manufacturing

6.4.1 Overview and Analysis

6.4.2 United States (US) Biologics Market Revenues & Volume, By Outsourced, 2016 - 2026F

6.4.3 United States (US) Biologics Market Revenues & Volume, By In-house, 2016 - 2026F

7 United States (US) Biologics Market Import-Export Trade Statistics

7.1 United States (US) Biologics Market Export to Major Countries

7.2 United States (US) Biologics Market Imports from Major Countries

8 United States (US) Biologics Market Key Performance Indicators

9 United States (US) Biologics Market - Opportunity Assessment

9.1 United States (US) Biologics Market Opportunity Assessment, By Source, 2019 & 2026F

9.2 United States (US) Biologics Market Opportunity Assessment, By Product Type, 2019 & 2026F

9.3 United States (US) Biologics Market Opportunity Assessment, By Diseaseย  Category, 2019 & 2026F

9.4 United States (US) Biologics Market Opportunity Assessment, By Biologics Manufacturing, 2019 & 2026F

10 United States (US) Biologics Market - Competitive Landscape

10.1 United States (US) Biologics Market Revenue Share, By Companies, 2023

10.2 United States (US) Biologics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All